XML 78 R30.htm IDEA: XBRL DOCUMENT
v3.10.0.1

Supplemental Condensed Consolidating Financial Information | 12 Months Ended
--- | ---
Dec. 31, 2018
Condensed Financial Information [Abstract] |
Supplemental Condensed Consolidating Financial Information | Supplemental Condensed Consolidating Financial Information On November 10, 2015, the Parent issued $700 million aggregate principal amount of the 5.375% Notes in a private placement to institutional investors. The 5.375% Notes were registered with the SEC in September 2016. Pursuant to the terms of the indenture governing the 5.375% Notes (the “Indenture”), the 5.375% Notes are required to be guaranteed by each of the Parent’s existing and future direct and indirect domestic restricted subsidiaries that guarantee the Parent’s Credit Agreement. At the time of issuance, there were two subsidiaries of the Parent that guaranteed the Notes: MMS and Molina Medical Management, Inc. (“MMM”). On November 1, 2015, the Parent acquired all of the outstanding ownership interests of Pathways Health and Community Support LLC (“Pathways”). As a result of that acquisition, and pursuant to the terms of the Indenture, effective February 16, 2016, Pathways and 15 of its subsidiaries were added as guarantors of the 5.375% Notes. Subsequently, effective January 3, 2017, MMM and 14 Pathways subsidiaries were released as guarantors of the 5.375% Notes, leaving MMS, Pathways, and Molina Pathways, LLC as the only subsidiary guarantors. MMS and Pathways were released as guarantors effective September 30, 2018, and October 19, 2018, respectively, in connection with their divestitures. Accordingly, as of December 31, 2018, Molina Pathways, LLC was the sole wholly owned subsidiary guarantor of the 5.375% Notes, on a full and unconditional basis. As discussed in Note 11, “Debt,” effective as of January 31, 2019, Molina Pathways, LLC was released as a guarantor of the 5.375% Notes. For all periods presented, the following condensed consolidating financial statements present Molina Healthcare, Inc. (as “Parent Issuer”), Molina Pathways, LLC (as “Other Guarantor”), the subsidiary non-guarantors (as “Non-Guarantors”) and “Eliminations,” according to the guarantor structure as assessed as of and for the year ended December 31, 2018. CONDENSED CONSOLIDATING STATEMENTS OF OPERATIONS
| Year Ended December 31, 2018
| Parent Issuer |  | Other Guarantor |  | Non-Guarantors |  | Eliminations |  | Consolidated
| (In millions)
Revenue: |  |  |  |  |  |  |  |  |
Total revenue | $ | 1,155 |  |  | $ | 3 |  |  | $ | 18,884 |  |  | $ | (1,152 | ) |  | $ | 18,890 |
Expenses: |  |  |  |  |  |  |  |  |
Medical care costs | 8 |  |  | — |  |  | 15,129 |  |  | — |  |  | 15,137 |
Cost of service revenue | — |  |  | — |  |  | 364 |  |  | — |  |  | 364 |
General and administrative expenses | 1,007 |  |  | 4 |  |  | 1,474 |  |  | (1,152 | ) |  | 1,333 |
Premium tax expenses | — |  |  | — |  |  | 417 |  |  | — |  |  | 417 |
Health insurer fees | — |  |  | — |  |  | 348 |  |  | — |  |  | 348 |
Depreciation and amortization | 69 |  |  | — |  |  | 30 |  |  | — |  |  | 99 |
Restructuring and separation costs | 35 |  |  | — |  |  | 11 |  |  | — |  |  | 46 |
Total operating expenses | 1,119 |  |  | 4 |  |  | 17,773 |  |  | (1,152 | ) |  | 17,744 |
Gain (loss) on sales of subsidiaries | 37 |  |  | (52 | ) |  | — |  |  | — |  |  | (15 | )
Operating income (loss) | 73 |  |  | (53 | ) |  | 1,111 |  |  | — |  |  | 1,131 |
Interest expense | 114 |  |  | — |  |  | 1 |  |  | — |  |  | 115 |
Other expense | 17 |  |  | — |  |  | — |  |  | — |  |  | 17 |
(Loss) income before income tax (benefit) expense | (58 | ) |  | (53 | ) |  | 1,110 |  |  | — |  |  | 999 |
Income tax (benefit) expense | (14 | ) |  | (11 | ) |  | 317 |  |  | — |  |  | 292 |
Net (loss) income before equity in net earnings (losses) of subsidiaries | (44 | ) |  | (42 | ) |  | 793 |  |  | — |  |  | 707 |
Equity in net earnings (losses) of subsidiaries | 751 |  |  | (5 | ) |  | — |  |  | (746 | ) |  | — |
Net income (loss) | $ | 707 |  |  | $ | (47 | ) |  | $ | 793 |  |  | $ | (746 | ) |  | $ | 707 |
| Year Ended December 31, 2017
| Parent Issuer |  | Other Guarantor |  | Non-Guarantors |  | Eliminations |  | Consolidated
| (In millions)
Revenue: |  |  |  |  |  |  |  |  |
Total revenue | $ | 1,333 |  |  | $ | 2 |  |  | $ | 19,904 |  |  | $ | (1,356 | ) |  | $ | 19,883 |
Expenses: |  |  |  |  |  |  |  |  |
Medical care costs | 16 |  |  | — |  |  | 17,058 |  |  | (1 | ) |  | 17,073 |
Cost of service revenue | — |  |  | — |  |  | 492 |  |  | — |  |  | 492 |
General and administrative expenses | 1,082 |  |  | 2 |  |  | 1,865 |  |  | (1,355 | ) |  | 1,594 |
Premium tax expenses | — |  |  | — |  |  | 438 |  |  | — |  |  | 438 |
Depreciation and amortization | 93 |  |  | — |  |  | 44 |  |  | — |  |  | 137 |
Restructuring and separation costs | 153 |  |  | — |  |  | 81 |  |  | — |  |  | 234 |
Impairment losses | 39 |  |  | — |  |  | 431 |  |  | — |  |  | 470 |
Total operating expenses | 1,383 |  |  | 2 |  |  | 20,409 |  |  | (1,356 | ) |  | 20,438 |
Operating loss | (50 | ) |  | — |  |  | (505 | ) |  | — |  |  | (555 | )
Total other expenses, net | 56 |  |  | — |  |  | 1 |  |  | — |  |  | 57 |
Loss before income taxes | (106 | ) |  | — |  |  | (506 | ) |  | — |  |  | (612 | )
Income tax expense (benefit) | 8 |  |  | — |  |  | (108 | ) |  | — |  |  | (100 | )
Net loss before equity in net (losses) earnings of subsidiaries | (114 | ) |  | — |  |  | (398 | ) |  | — |  |  | (512 | )
Equity in net (losses) earnings of subsidiaries | (398 | ) |  | (164 | ) |  | 8 |  |  | 554 |  |  | — |
Net loss | $ | (512 | ) |  | $ | (164 | ) |  | $ | (390 | ) |  | $ | 554 |  |  | $ | (512 | )
| Year Ended December 31, 2016
| Parent Issuer |  | Other Guarantor |  | Non-Guarantors |  | Eliminations |  | Consolidated
| (In millions)
Revenue: |  |  |  |  |  |  |  |  |
Total revenue | $ | 1,078 |  |  | $ | — |  |  | $ | 17,786 |  |  | $ | (1,082 | ) |  | $ | 17,782 |
Expenses: |  |  |  |  |  |  |  |  |
Medical care costs | 73 |  |  | — |  |  | 14,702 |  |  | (1 | ) |  | 14,774 |
Cost of service revenue | — |  |  | — |  |  | 485 |  |  | — |  |  | 485 |
General and administrative expenses | 899 |  |  | 2 |  |  | 1,573 |  |  | (1,081 | ) |  | 1,393 |
Premium tax expenses | — |  |  | — |  |  | 468 |  |  | — |  |  | 468 |
Health insurer fees | — |  |  | — |  |  | 217 |  |  | — |  |  | 217 |
Depreciation and amortization | 95 |  |  | — |  |  | 44 |  |  | — |  |  | 139 |
Total operating expenses | 1,067 |  |  | 2 |  |  | 17,489 |  |  | (1,082 | ) |  | 17,476 |
Operating income (loss) | 11 |  |  | (2 | ) |  | 297 |  |  | — |  |  | 306 |
Total other expenses, net | 101 |  |  | — |  |  | — |  |  | — |  |  | 101 |
(Loss) income before income taxes | (90 | ) |  | (2 | ) |  | 297 |  |  | — |  |  | 205 |
Income tax (benefit) expense | (24 | ) |  | (1 | ) |  | 178 |  |  | — |  |  | 153 |
Net (loss) income before equity in earnings of subsidiaries | (66 | ) |  | (1 | ) |  | 119 |  |  | — |  |  | 52 |
Equity in net earnings of subsidiaries | 118 |  |  | 2 |  |  | — |  |  | (120 | ) |  | — |
Net income | $ | 52 |  |  | $ | 1 |  |  | $ | 119 |  |  | $ | (120 | ) |  | $ | 52 |
CONDENSED CONSOLIDATING STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
| Year Ended December 31, 2018
| Parent Issuer |  | Other Guarantor |  | Non-Guarantors |  | Eliminations |  | Consolidated
| (In millions)
Net income (loss) | $ | 707 |  |  | $ | (47 | ) |  | $ | 793 |  |  | $ | (746 | ) |  | $ | 707 |
Other comprehensive loss, net of tax | (2 | ) |  | — |  |  | (2 | ) |  | 2 |  |  | (2 | )
Comprehensive income (loss) | $ | 705 |  |  | $ | (47 | ) |  | $ | 791 |  |  | $ | (744 | ) |  | $ | 705 |
| Year Ended December 31, 2017
| Parent Issuer |  | Other Guarantor |  | Non-Guarantors |  | Eliminations |  | Consolidated
| (In millions)
Net loss | $ | (512 | ) |  | $ | (164 | ) |  | $ | (390 | ) |  | $ | 554 |  |  | $ | (512 | )
Other comprehensive loss, net of tax | (3 | ) |  | — |  |  | (2 | ) |  | 2 |  |  | (3 | )
Comprehensive loss | $ | (515 | ) |  | $ | (164 | ) |  | $ | (392 | ) |  | $ | 556 |  |  | $ | (515 | )
| Year Ended December 31, 2016
| Parent Issuer |  | Other Guarantor |  | Non-Guarantors |  | Eliminations |  | Consolidated
| (In millions)
Net income | $ | 52 |  |  | $ | 1 |  |  | $ | 119 |  |  | $ | (120 | ) |  | $ | 52 |
Other comprehensive income, net of tax | 2 |  |  | — |  |  | 1 |  |  | (1 | ) |  | 2 |
Comprehensive income | $ | 54 |  |  | $ | 1 |  |  | $ | 120 |  |  | $ | (121 | ) |  | $ | 54 |
CONDENSED CONSOLIDATING BALANCE SHEETS
| December 31, 2018
| Parent Issuer |  | Other Guarantor |  | Non-Guarantors |  | Eliminations |  | Consolidated
| (In millions)
ASSETS
Current assets: |  |  |  |  |  |  |  |  |
Cash and cash equivalents | $ | 70 |  |  | $ | 2 |  |  | $ | 2,754 |  |  | $ | — |  |  | $ | 2,826 |
Investments | 100 |  |  | — |  |  | 1,581 |  |  | — |  |  | 1,681 |
Receivables | 2 |  |  | — |  |  | 1,328 |  |  | — |  |  | 1,330 |
Due from (to) affiliates | 90 |  |  | 7 |  |  | (97 | ) |  | — |  |  | — |
Prepaid expenses and other current assets | 47 |  |  | 29 |  |  | 73 |  |  | — |  |  | 149 |
Derivative asset | 476 |  |  | — |  |  | — |  |  | — |  |  | 476 |
Total current assets | 785 |  |  | 38 |  |  | 5,639 |  |  | — |  |  | 6,462 |
Property, equipment, and capitalized software, net | 176 |  |  | — |  |  | 65 |  |  | — |  |  | 241 |
Goodwill and intangible assets, net | 13 |  |  | — |  |  | 177 |  |  | — |  |  | 190 |
Restricted investments | — |  |  | — |  |  | 120 |  |  | — |  |  | 120 |
Investment in subsidiaries, net | 2,768 |  |  | (5 | ) |  | — |  |  | (2,763 | ) |  | — |
Deferred income taxes | 39 |  |  | — |  |  | 78 |  |  | — |  |  | 117 |
Other assets | 40 |  |  | — |  |  | 5 |  |  | (21 | ) |  | 24 |
| $ | 3,821 |  |  | $ | 33 |  |  | $ | 6,084 |  |  | $ | (2,784 | ) |  | $ | 7,154 |
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities: |  |  |  |  |  |  |  |  |
Medical claims and benefits payable | $ | 4 |  |  | $ | — |  |  | $ | 1,957 |  |  | $ | — |  |  | $ | 1,961 |
Amounts due government agencies | — |  |  | — |  |  | 967 |  |  | — |  |  | 967 |
Accounts payable and accrued liabilities | 223 |  |  | — |  |  | 167 |  |  | — |  |  | 390 |
Deferred revenue | — |  |  | — |  |  | 211 |  |  | — |  |  | 211 |
Current portion of long-term debt | 241 |  |  | — |  |  | — |  |  | — |  |  | 241 |
Derivative liability | 476 |  |  | — |  |  | — |  |  | — |  |  | 476 |
Total current liabilities | 944 |  |  | — |  |  | 3,302 |  |  | — |  |  | 4,246 |
Long-term debt and lease financing obligations | 1,217 |  |  | — |  |  | 20 |  |  | (20 | ) |  | 1,217 |
Other long-term liabilities | 13 |  |  | — |  |  | 32 |  |  | (1 | ) |  | 44 |
Total liabilities | 2,174 |  |  | — |  |  | 3,354 |  |  | (21 | ) |  | 5,507 |
Total stockholders’ equity | 1,647 |  |  | 33 |  |  | 2,730 |  |  | (2,763 | ) |  | 1,647 |
| $ | 3,821 |  |  | $ | 33 |  |  | $ | 6,084 |  |  | $ | (2,784 | ) |  | $ | 7,154 |
CONDENSED CONSOLIDATING BALANCE SHEETS
| December 31, 2017
| Parent Issuer |  | Other Guarantor |  | Non-Guarantors |  | Eliminations |  | Consolidated
| (In millions)
ASSETS
Current assets: |  |  |  |  |  |  |  |  |
Cash and cash equivalents | $ | 504 |  |  | $ | — |  |  | $ | 2,682 |  |  | $ | — |  |  | $ | 3,186 |
Investments | 192 |  |  | — |  |  | 2,332 |  |  | — |  |  | 2,524 |
Restricted investments | 169 |  |  | — |  |  | — |  |  | — |  |  | 169 |
Receivables | 2 |  |  | — |  |  | 869 |  |  | — |  |  | 871 |
Due from (to) affiliates | 148 |  |  | 2 |  |  | (150 | ) |  | — |  |  | — |
Prepaid expenses and other current assets | 103 |  |  | 2 |  |  | 150 |  |  | (16 | ) |  | 239 |
Derivative asset | 522 |  |  | — |  |  | — |  |  | — |  |  | 522 |
Total current assets | 1,640 |  |  | 4 |  |  | 5,883 |  |  | (16 | ) |  | 7,511 |
Property, equipment, and capitalized software, net | 223 |  |  | — |  |  | 119 |  |  | — |  |  | 342 |
Goodwill and intangible assets, net | 15 |  |  | — |  |  | 240 |  |  | — |  |  | 255 |
Restricted investments | — |  |  | — |  |  | 119 |  |  | — |  |  | 119 |
Investment in subsidiaries, net | 2,306 |  |  | 75 |  |  | — |  |  | (2,381 | ) |  | — |
Deferred income taxes | 17 |  |  | — |  |  | 101 |  |  | (15 | ) |  | 103 |
Other assets | 32 |  |  | — |  |  | 110 |  |  | (1 | ) |  | 141 |
| $ | 4,233 |  |  | $ | 79 |  |  | $ | 6,572 |  |  | $ | (2,413 | ) |  | $ | 8,471 |
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities: |  |  |  |  |  |  |  |  |
Medical claims and benefits payable | $ | 3 |  |  | $ | — |  |  | $ | 2,189 |  |  | $ | — |  |  | $ | 2,192 |
Amounts due government agencies | — |  |  | — |  |  | 1,542 |  |  | — |  |  | 1,542 |
Accounts payable and accrued liabilities | 178 |  |  | 1 |  |  | 188 |  |  | (1 | ) |  | 366 |
Deferred revenue | — |  |  | — |  |  | 282 |  |  | — |  |  | 282 |
Current portion of long-term debt | 653 |  |  | — |  |  | 16 |  |  | (16 | ) |  | 653 |
Derivative liability | 522 |  |  | — |  |  | — |  |  | — |  |  | 522 |
Total current liabilities | 1,356 |  |  | 1 |  |  | 4,217 |  |  | (17 | ) |  | 5,557 |
Long-term debt and lease financing obligations | 1,516 |  |  | — |  |  | — |  |  | — |  |  | 1,516 |
Deferred income taxes | — |  |  | — |  |  | 15 |  |  | (15 | ) |  | — |
Other long-term liabilities | 24 |  |  | — |  |  | 37 |  |  | — |  |  | 61 |
Total liabilities | 2,896 |  |  | 1 |  |  | 4,269 |  |  | (32 | ) |  | 7,134 |
Total stockholders’ equity | 1,337 |  |  | 78 |  |  | 2,303 |  |  | (2,381 | ) |  | 1,337 |
| $ | 4,233 |  |  | $ | 79 |  |  | $ | 6,572 |  |  | $ | (2,413 | ) |  | $ | 8,471 |
CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS
| Year Ended December 31, 2018
| Parent Issuer |  | Other Guarantor |  | Non-Guarantors |  | Eliminations |  | Consolidated
| (In millions)
Operating activities: |  |  |  |  |  |  |  |  |
Net cash provided by (used in) operating activities | $ | 118 |  |  | (2 | ) |  | (430 | ) |  | — |  |  | $ | (314 | )
Investing activities: |  |  |  |  |  |  |  |  |
Purchases of investments | (136 | ) |  | — |  |  | (1,308 | ) |  | — |  |  | (1,444 | )
Proceeds from sales and maturities of investments | 388 |  |  | — |  |  | 2,057 |  |  | — |  |  | 2,445 |
Purchases of property, equipment and capitalized software | (22 | ) |  | — |  |  | (8 | ) |  | — |  |  | (30 | )
Net cash received from sales of subsidiaries | 242 |  |  | — |  |  | (52 | ) |  | — |  |  | 190 |
Capital contributions to subsidiaries | (145 | ) |  | — |  |  | 145 |  |  | — |  |  | — |
Dividends received from subsidiaries | 298 |  |  | — |  |  | (298 | ) |  | — |  |  | — |
Change in amounts due to/from affiliates | 6 |  |  | 4 |  |  | (10 | ) |  | — |  |  | — |
Other, net | — |  |  | — |  |  | (18 | ) |  | — |  |  | (18 | )
Net cash provided by investing activities | 631 |  |  | 4 |  |  | 508 |  |  | — |  |  | 1,143 |
Financing activities: |  |  |  |  |  |  |  |  |
Repayment of credit facility | (300 | ) |  | — |  |  | — |  |  | — |  |  | (300 | )
Repayment of principal amount of 1.125% Convertible Notes | (298 | ) |  | — |  |  | — |  |  | — |  |  | (298 | )
Cash paid for partial settlement of 1.125% Conversion Option | (623 | ) |  | — |  |  | — |  |  | — |  |  | (623 | )
Cash received for partial settlement of 1.125% Call Option | 623 |  |  | — |  |  | — |  |  | — |  |  | 623 |
Cash paid for partial termination of 1.125% Warrants | (549 | ) |  | — |  |  | — |  |  | — |  |  | (549 | )
Repayment of principal amount of 1.625% Convertible Notes | (64 | ) |  | — |  |  | — |  |  | — |  |  | (64 | )
Other, net | 19 |  |  | — |  |  | (1 | ) |  | — |  |  | 18 |
Net cash used in financing activities | (1,192 | ) |  | — |  |  | (1 | ) |  | — |  |  | (1,193 | )
Net (decrease) increase in cash, cash equivalents, and restricted cash and cash equivalents | (443 | ) |  | 2 |  |  | 77 |  |  | — |  |  | (364 | )
Cash, cash equivalents, and restricted cash and cash equivalents at beginning of period | 513 |  |  | — |  |  | 2,777 |  |  | — |  |  | 3,290 |
Cash, cash equivalents, and restricted cash and cash equivalents at end of period | $ | 70 |  |  | $ | 2 |  |  | $ | 2,854 |  |  | $ | — |  |  | $ | 2,926 |
| Year Ended December 31, 2017
| Parent Issuer |  | Other Guarantor |  | Non-Guarantors |  | Eliminations |  | Consolidated
| (In millions)
Operating activities: |  |  |  |  |  |  |  |  |
Net cash provided by operating activities | $ | 166 |  |  | — |  |  | 638 |  |  | — |  |  | $ | 804 |
Investing activities: |  |  |  |  |  |  |  |  |
Purchases of investments | (331 | ) |  | — |  |  | (2,366 | ) |  | — |  |  | (2,697 | )
Proceeds from sales and maturities of investments | 156 |  |  | — |  |  | 1,603 |  |  | — |  |  | 1,759 |
Purchases of property, equipment and capitalized software | (67 | ) |  | — |  |  | (19 | ) |  | — |  |  | (86 | )
Capital contributions to subsidiaries | (370 | ) |  | 2 |  |  | 368 |  |  | — |  |  | — |
Dividends received from subsidiaries | 286 |  |  | — |  |  | (286 | ) |  | — |  |  | — |
Change in amounts due to/from affiliates | (49 | ) |  | (2 | ) |  | 51 |  |  | — |  |  | — |
Other, net | — |  |  | — |  |  | (38 | ) |  | — |  |  | (38 | )
Net cash used in investing activities | (375 | ) |  | — |  |  | (687 | ) |  | — |  |  | (1,062 | )
Financing activities: |  |  |  |  |  |  |  |  |
Proceeds from senior notes offerings, net of issuance costs | 325 |  |  | — |  |  | — |  |  | — |  |  | 325 |
Proceeds from borrowings under credit facility | 300 |  |  | — |  |  | — |  |  | — |  |  | 300 |
Other, net | 11 |  |  | — |  |  | — |  |  | — |  |  | 11 |
Net cash provided by financing activities | 636 |  |  | — |  |  | — |  |  | — |  |  | 636 |
Net increase (decrease) in cash, cash equivalents, and restricted cash and cash equivalents | 427 |  |  | — |  |  | (49 | ) |  | — |  |  | 378 |
Cash, cash equivalents, and restricted cash and cash equivalents at beginning of period | 86 |  |  | — |  |  | 2,826 |  |  | — |  |  | 2,912 |
Cash, cash equivalents, and restricted cash and cash equivalents at end of period | $ | 513 |  |  | $ | — |  |  | $ | 2,777 |  |  | $ | — |  |  | $ | 3,290 |
| Year Ended December 31, 2016
| Parent Issuer |  | Other Guarantor |  | Non-Guarantors |  | Eliminations |  | Consolidated
| (In millions)
Operating activities: |  |  |  |  |  |  |  |  |
Net cash provided by (used in) operating activities | $ | 55 |  |  | (1 | ) |  | 619 |  |  | — |  |  | $ | 673 |
Investing activities: |  |  |  |  |  |  |  |  |
Purchases of investments | (115 | ) |  | — |  |  | (1,814 | ) |  | — |  |  | (1,929 | )
Proceeds from sales and maturities of investments | 188 |  |  | — |  |  | 1,778 |  |  | — |  |  | 1,966 |
Purchases of property, equipment and capitalized software | (125 | ) |  | — |  |  | (51 | ) |  | — |  |  | (176 | )
Net cash paid in business combinations | — |  |  | — |  |  | (48 | ) |  | — |  |  | (48 | )
Capital contributions to subsidiaries | (386 | ) |  | 7 |  |  | 379 |  |  | — |  |  | — |
Dividends received from subsidiaries | 101 |  |  | — |  |  | (101 | ) |  | — |  |  | — |
Change in amounts due to/from affiliates | (18 | ) |  | (6 | ) |  | 24 |  |  | — |  |  | — |
Other, net | 6 |  |  | — |  |  | (25 | ) |  | — |  |  | (19 | )
Net cash (used in) provided by investing activities | (349 | ) |  | 1 |  |  | 142 |  |  | — |  |  | (206 | )
Financing activities: |  |  |  |  |  |  |  |  |
Other, net | 20 |  |  | — |  |  | (1 | ) |  | — |  |  | 19 |
Net cash provided by (used in) financing activities | 20 |  |  | — |  |  | (1 | ) |  | — |  |  | 19 |
Net increase (decrease) in cash, cash equivalents, and restricted cash and cash equivalents | (274 | ) |  | — |  |  | 760 |  |  | — |  |  | 486 |
Cash, cash equivalents, and restricted cash and cash equivalents at beginning of period | 360 |  |  | — |  |  | 2,066 |  |  | — |  |  | 2,426 |
Cash, cash equivalents, and restricted cash and cash equivalents at end of period | $ | 86 |  |  | $ | — |  |  | $ | 2,826 |  |  | $ | — |  |  | $ | 2,912 |

X
- Definition Condensed Financial Information [Abstract] + References No definition available. + Details
Name: | moh_CondensedFinancialInformationAbstract
Namespace Prefix: | moh_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for condensed financial statements. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 3 -Paragraph d -Subparagraph 4 -Subsection 10 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 3 -Paragraph c -Subparagraph 4 -Subsection 10 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 12 -Paragraph a -Subsection 04 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 3 -Paragraph e -Subparagraph 4 -Subsection 10 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 3 -Paragraph f -Subparagraph 4 -Subsection 10 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-04(a)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e24072-122690 + Details
Name: | srt_CondensedFinancialStatementsTextBlock
Namespace Prefix: | srt_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration